Eraxis should be administered as a single intravenous infusion over 3 hours. It must not be administered as a bolus injection. Reconstitute the vial with Sterile Water for Injection, then further dilute in 0.9% sodium chloride or 5% dextrose solution.

Anidulafungin inhibits 1,3-β-D-glucan synthase, an enzyme critical for the synthesis of 1,3-β-D-glucan, a major component of the fungal cell wall. This leads to osmotic instability and fungal cell death.

• •Known hypersensitivity to anidulafungin or any other echinocandin.

Store intact vials refrigerated at 2°C to 8°C (36°F to 46°F). Do not freeze. Reconstituted and diluted solutions have specific stability guidelines.

In the event of an overdose, there is limited clinical experience. Supportive measures should be initiated as appropriate. Anidulafungin is not dialyzable.

Pregnancy Category C. Use only if the potential benefit justifies the potential risk to the fetus. It is unknown whether anidulafungin is excreted in human milk; caution should be exercised when administered to a nursing woman.